International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7847950
Original Article
Clinical and Radiological Features and Outcome of Hospitalized Patients with CNS Tuberculosis : A Prospective Observational Study in A Tertiary Care Centre, Mumbai
 ,
 ,
 ,
 ,
 ,
Published
April 20, 2023
Abstract
Background: Tuberculosis (TB) is a major public health problem in India. Ten percent of all patients with TB have CNS involvement. Delayed diagnosis of this disease is associated with increased mortality. This study assesses the clinico-radiological features as well as outcomes in patients with various forms of CNS TB. Methods: A prospective observational study conducted at tertiary care centre Mumbai between January 2020-July 2022.Each patient was assessed from admission to 3- month follow up. Detailed clinical examination including lab examination was done. All patients were divided into different categories based on Singhal staging and Modified MRC grading for TBM. APACHE 2 score was evaluated for severity of illness. Outcome was measured in terms of mortality and morbidity. Results: Our study had 70 patients with a mean age of 38.94 ± 20.75 years. Fever was the most common symptom in patients with TBM (98.57%).Of total 70 enrolled cases it was found that 57(81.43%) patients survived whereas 13(18.57%) were expired. Co infection with HIV, HBV as well as basal exudate, hydrocephalus, infarct and tuberculoma on CT were significant predictor for mortality in CNS TB. Conclusions: Mortality rate in CNS TB is high. With optimal medical management and timely surgical interventions like Ventriculoperitoneal shunt , External Ventricular Drain (EVD), Decompression Craniotomy many lives can be saved.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
393 Views
474 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved